Reported segment mix · SEC DERA dimensional facts

Scientist Home Future Health Ltd SHFH revenue by segment, product and geography

In its fiscal year ending 2025-12-31, Scientist Home Future Health Ltd reported revenue across 2 business segments; the largest, Retail Trading Business B, was $197K, 96.8% of the filed sum.

Full financial analysis →Company overview →

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing

Fiscal year ending 2025-12-3110-K filed 2026-03-27View filing

By business segment

Revenue

Retail Trading Business B$197K
96.8%
no prior
Service Business$6.61K
3.2%
no prior

Members sum to the consolidated $204K for this period.

By product or service

Revenue

Scientist Home Mixed Gelatine Hydrolysate$60.5K
30.6%
no prior
Others Delivery Fee$47.8K
24.2%
no prior
Scientist Home High Concentration Proteinase$43.8K
22.2%
no prior
Scientist Home Vein Cream$22.6K
11.5%
no prior
Scientist Home Cholipolysis Cholic Acid$13.4K
6.8%
no prior
Scientist Home Bone Gelatine Hydrolysate$9.42K
4.8%
no prior

Members sum to the consolidated $197K for this period.

By geography

Revenue

Non Hong Kong$0
share n/a
no prior

Members sum to $0 against $204K consolidated (residual $204K) - eliminations or corporate lines the filer did not tag on this axis.

Latest quarter

Quarter ending 2026-03-3110-Q filed 2026-05-14prior period 2025-03-31 from the same filingView filing

Retail Trading Business B$182K
96.6%
+306.7% yoy
Service Business$6.48K
3.4%
no prior

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

About these figures

Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.

Descriptive and educational; not investment advice. Methodology and data lineage.